{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:18:23Z","timestamp":1792653503577,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.advms.2021.09.002","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T01:43:28Z","timestamp":1632275008000},"page":"10-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of the safety and efficacy of AdvaxTM as an adjuvant: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"67","author":[{"given":"Irem","family":"Akin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1769-4171","authenticated-orcid":false,"given":"Sevginur","family":"Akdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve Nur","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda","family":"Altiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5047-7881","authenticated-orcid":false,"given":"Pelin","family":"Aribal Ayral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1237-8468","authenticated-orcid":false,"given":"Nuray","family":"Yazihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2021.09.002_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ebiom.2016.11.015","article-title":"Advax, a delta inulin microparticle, potentiates in-built adjuvant property of Co-administered vaccines","volume":"15","author":"Hayashi","year":"2017","journal-title":"EBioMedicine"},{"issue":"39","key":"10.1016\/j.advms.2021.09.002_bib2","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1073\/pnas.0603493103","article-title":"Activation of NF-\u03baB by the intracellular expression of NF-\u03baB-inducing kinase acts as a powerful vaccine adjuvant","volume":"103","author":"Andreakos","year":"2006","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"10.1016\/j.advms.2021.09.002_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-\u03baB by toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.advms.2021.09.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-14965-x","article-title":"Constitutive expression of NF-\u03baB inducing kinase in regulatory T cells impairs suppressive function and promotes instability and pro-inflammatory cytokine production","volume":"7","author":"Polesso","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.advms.2021.09.002_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal transduction and targeted therapy"},{"issue":"4","key":"10.1016\/j.advms.2021.09.002_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1586\/erv.11.30","article-title":"Carbohydrate-based immune adjuvants","volume":"10","author":"Petrovsky","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"10.1016\/j.advms.2021.09.002_bib7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nm.2403","article-title":"DNA released from dying host cells mediates aluminum adjuvant activity","volume":"17","author":"Marichal","year":"2011","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.advms.2021.09.002_bib8","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/IAI.71.5.2498-2507.2003","article-title":"Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A","volume":"71","author":"Martin","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.advms.2021.09.002_bib9","series-title":"Advax adjuvant: a potent and safe immunopotentiator composed of delta inulin. Immunopotentiators in modern vaccines","first-page":"199","author":"Petroski","year":"2017"},{"issue":"36","key":"10.1016\/j.advms.2021.09.002_bib10","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.vaccine.2012.06.021","article-title":"Advax\u2122, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses","volume":"30","author":"Honda-Okubo","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.advms.2021.09.002_bib11","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3390\/nu7043011","article-title":"Vitamin D and 1, 25 (OH) 2D regulation of T cells","volume":"7","author":"Cantorna","year":"2015","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.advms.2021.09.002_bib12","first-page":"309","article-title":"Arthritis, a complex connective and synovial joint destructive autoimmune disease: animal models of arthritis with varied etiopathology and their significance","volume":"60","author":"NSaW","year":"2014","journal-title":"J\u00a0Postgrad Med"},{"issue":"8","key":"10.1016\/j.advms.2021.09.002_bib13","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1128\/JVI.03144-12","article-title":"JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody","volume":"87","author":"Larena","year":"2013","journal-title":"J\u00a0Virol"},{"issue":"18","key":"10.1016\/j.advms.2021.09.002_bib14","doi-asserted-by":"crossref","first-page":"10324","DOI":"10.1128\/JVI.00480-13","article-title":"An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody","volume":"87","author":"Petrovsky","year":"2013","journal-title":"J\u00a0Virol"},{"issue":"15","key":"10.1016\/j.advms.2021.09.002_bib15","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.vaccine.2012.12.077","article-title":"A\u00a0novel hepatitis B vaccine containing Advax\u2122, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing","volume":"31","author":"Saade","year":"2013","journal-title":"Vaccine"},{"issue":"Pt 1","key":"10.1016\/j.advms.2021.09.002_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1099\/vir.0.023242-0","article-title":"Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations","volume":"92","author":"Cristillo","year":"2011","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.advms.2021.09.002_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-4939-3387-7_14","article-title":"Development of a SARS coronavirus vaccine from recombinant spike protein plus delta inulin adjuvant","volume":"1403","author":"McPherson","year":"2016","journal-title":"Methods Mol Biol"},{"issue":"12","key":"10.1016\/j.advms.2021.09.002_bib18","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.vaccine.2015.01.062","article-title":"A\u00a0gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax\u2122 delta inulin adjuvant induces robust T-cell protection against listeria infection","volume":"33","author":"Rodriguez-Del Rio","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.advms.2021.09.002_bib19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/CVI.00019-14","article-title":"Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant","volume":"21","author":"Feinen","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.advms.2021.09.002_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"issue":"7414","key":"10.1016\/j.advms.2021.09.002_bib21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"key":"10.1016\/j.advms.2021.09.002_bib22","first-page":"85","article-title":"Fixed-effect versus random-effects models","volume":"77","author":"Borenstein","year":"2009","journal-title":"Introduction to Meta-analysis"},{"key":"10.1016\/j.advms.2021.09.002_bib23","series-title":"Cochrane handbook for systematic reviews of interventions","year":"2011"},{"issue":"36","key":"10.1016\/j.advms.2021.09.002_bib24","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1016\/j.vaccine.2012.06.009","article-title":"Randomized clinical trial of immunogenicity and safety of a recombinant H1N1\/2009 pandemic influenza vaccine containing Advax\u2122 polysaccharide adjuvant","volume":"30","author":"Gordon","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.advms.2021.09.002_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2017.1279765","article-title":"Panblok-H1+advax H1N1\/2009pdm vaccine: insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine","volume":"13","author":"Honda-Okubo","year":"2017","journal-title":"Hum Vaccines Immunother"},{"issue":"48","key":"10.1016\/j.advms.2021.09.002_bib26","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1016\/j.vaccine.2014.09.034","article-title":"Immunogenicity and safety of Advax\u2122, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study","volume":"32","author":"Gordon","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.advms.2021.09.002_bib27","article-title":"Delta inulin adjuvant enhances plasmablast generation, expression of activation-induced cytidine deaminase and B-cell affinity maturation in human subjects receiving seasonal influenza vaccine","volume":"10","author":"Li","year":"2015","journal-title":"PloS One"},{"issue":"33","key":"10.1016\/j.advms.2021.09.002_bib28","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2016.05.071","article-title":"Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax\u2122 delta inulin adjuvant","volume":"34","author":"Gordon","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.advms.2021.09.002_bib29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jaci.2019.03.035","article-title":"Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy","volume":"144","author":"Heddle","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"38","key":"10.1016\/j.advms.2021.09.002_bib30","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1016\/j.vaccine.2015.07.051","article-title":"Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection","volume":"33","author":"Honda-Okubo","year":"2015","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.advms.2021.09.002_bib31","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1016\/j.vaccine.2011.06.078","article-title":"Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets","volume":"29","author":"Layton","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.advms.2021.09.002_bib32","article-title":"Preliminary results on innocuity and immunogenicity of an inactivated vaccine against Peste des petits ruminants","volume":"52","author":"Ronchi","year":"2016","journal-title":"Vet Ital"},{"issue":"8","key":"10.1016\/j.advms.2021.09.002_bib33","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1080\/21645515.2016.1162931","article-title":"Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology","volume":"12","author":"Wong","year":"2016","journal-title":"Hum Vaccines Immunother"},{"issue":"Pt 6","key":"10.1016\/j.advms.2021.09.002_bib34","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1099\/vir.0.019190-0","article-title":"An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses","volume":"91","author":"Lobigs","year":"2010","journal-title":"J\u00a0Gen Virol"},{"issue":"1","key":"10.1016\/j.advms.2021.09.002_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13567-014-0130-7","article-title":"Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals","volume":"45","author":"Bielefeldt-Ohmann","year":"2014","journal-title":"Vet Res"},{"issue":"1","key":"10.1016\/j.advms.2021.09.002_bib36","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.1038\/s41598-017-09119-y","article-title":"Delta inulin-based adjuvants promote the generation of polyfunctional CD4(+) T cell responses and protection against Mycobacterium tuberculosis infection","volume":"7","author":"Counoupas","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.advms.2021.09.002_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2018.09.006","article-title":"Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge","volume":"288","author":"Tomar","year":"2018","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.advms.2021.09.002_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejps.2014.10.008","article-title":"Enhanced pulmonary immunization with aerosolized inactivated influenza vaccine containing delta inulin adjuvant","volume":"66","author":"Murugappan","year":"2015","journal-title":"Eur J Pharmaceut Sci"},{"issue":"105","key":"10.1016\/j.advms.2021.09.002_bib39","article-title":"Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis","volume":"5","author":"Counoupas","year":"2020","journal-title":"npj Vaccines"},{"issue":"6","key":"10.1016\/j.advms.2021.09.002_bib40","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1128\/JVI.02980-14","article-title":"Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology","volume":"89","author":"Honda-Okubo","year":"2015","journal-title":"J\u00a0Virol"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112621000481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112621000481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:39:52Z","timestamp":1761824392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112621000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1896112621000481"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2021.09.002","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the safety and efficacy of AdvaxTM as an adjuvant: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2021.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}